INmune Bio, Inc. (INMB) Q3 2022 Earnings Call Transcript
INmune Bio, Inc. (NASDAQ:NASDAQ:INMB) Q3 2022 Results Conference Call November 02, 2022 04:30 PM ET Company Participants David Moss - Chief Financial Officer Dr.
Stay updated with breaking news from Tailwinds Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
INmune Bio, Inc. (NASDAQ:NASDAQ:INMB) Q3 2022 Results Conference Call November 02, 2022 04:30 PM ET Company Participants David Moss - Chief Financial Officer Dr.
Operator Greetings, and welcome to the INmune Bio fourth-quarter 2020 earnings conference call. [Operator instructions] As a reminder, this conference call is being recorded. A transcript will follow within 24 hours of this conference call. At this time, it is my pleasure to introduce Mr. David Moss, co-founder and CFO of INmune Bio. David, the floor is yours. David Moss -- Co-Founder and Chief Executive Officer Thank you, Rob, and good afternoon, everybody. We thank you for joining us for the call for INmune Bio's fourth-quarter 2020 financial results. With me on the call is Dr. RJ Tesi, CE...